Methylprednisolone aceponate

DB14643ApprovedVet approvedSmall molecule

Methylprednisolone aceponate is a corticosteroid indicated in the treatment of corticosteroid-responsive dermatoses. A medication used to treat inflammation and other conditions of the skin.

Mechanism: Pharmacologically active on Glucocorticoid receptor
Curator reviewed
Formula / weight: C₂₇H₃₆O₇ · 472.578 g/mol (avg)
Code names: BRN 5663614 · SH-440 · ZK91588

Resolves to

Compound

UNIIET54W9J4U2CAS86401-95-8ChEMBLCHEMBL1697782ChEBI135762

Clinical / RWD

RxNorm62136ATCD07AC14

Structure

InChIKeyDALKLAYLIPSCQL-YPYQNWSCSA-NSMILES[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C

Targets

P04150NR3C1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

541Drug interactionsStructured to mechanism, not free text

5Clinical trialsPhase, status and sponsor resolved per trial

7Structured indicationsCondition, population, route and combination as fields, not prose

14ContraindicationsEach with its own population and attribute set

55Marketed productsAcross 5 countries and 9 labellers

1ATC codeIncluding every combination product, plus 11 drug categories

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Methylprednisolone aceponate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account